4.5581
+0.0081
+(0.18%)
As of 12:40:17 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-29,384
-29,384
-33,104
-34,970
-15,278
Investing Cash Flow
-231
-231
-1,675
-6
-7
Financing Cash Flow
31,202
31,202
23,181
43,937
19,492
End Cash Position
8,002
8,002
5,469
17,051
8,090
Interest Paid Supplemental Data
14
14
23
28
757
Capital Expenditure
-231
-231
-1,675
-6
-7
Issuance of Capital Stock
31,910
31,910
20,462
33,578
1,949
Issuance of Debt
--
--
3,975
10,975
12,300
Repayment of Debt
-100
-100
-100
-1,922
-6,613
Free Cash Flow
-29,615
-29,615
-34,779
-34,976
-15,285
12/31/2020 - 5/12/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OCGN Ocugen, Inc.
0.6564
+2.77%
ADTX Aditxt, Inc.
4.7092
-15.79%
IBIO iBio, Inc. Common Stock
3.3500
-11.84%
VINC Vincerx Pharma, Inc.
0.6090
-7.70%
VXRT Vaxart, Inc.
0.3440
-9.28%
REVB Revelation Biosciences, Inc.
2.6800
-4.09%
VRPX Virpax Pharmaceuticals, Inc.
0.6695
-45.12%
BDRX Biodexa Pharmaceuticals Plc
1.7500
+19.05%
TNXP Tonix Pharmaceuticals Holding Corp.
15.10
-13.66%
CDT Conduit Pharmaceuticals Inc.
0.6002
-12.43%